OVID Latest Press Releases

-- June 4, 2026 --

Ovid Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- June 3, 2026 --

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors Globe Newswire 7:00 AM

-- May 12, 2026 --

Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results Globe Newswire 7:00 AM

-- April 8, 2026 --

Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14 Globe Newswire 8:00 AM

-- March 18, 2026 --

Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 6:05 AM

Ovid Therapeutics Announces Pricing of $60 Million Private Placement Globe Newswire 6:00 AM

-- February 25, 2026 --

Ovid Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software